Clinical trialNCT02445222RecruitingPhase 3Interventional

CAR-T Long Term Follow Up (LTFU) Study

SponsorNovartis PharmaceuticalsEnrollment1,400Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Novartis Pharmaceuticals
Novartis Pharmaceuticals
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

118 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Novartis Investigative Site
Camperdown, New South Wales, Australia
Recruiting
Novartis Investigative Site
Melbourne, Victoria, Australia
Recruiting
Novartis Investigative Site
Melbourne, Victoria, Australia
Recruiting
Novartis Investigative Site
Parkville, Victoria, Australia
Withdrawn
Novartis Investigative Site
Murdoch, Western Australia, Australia
Recruiting
Novartis Investigative Site
Herston, Australia
Recruiting

Austria

Novartis Investigative Site
Linz, Austria
Withdrawn
Novartis Investigative Site
Salzburg, Austria
Recruiting
Novartis Investigative Site
Vienna, Austria
Recruiting
Novartis Investigative Site
Vienna, Austria
Recruiting

Belgium

Novartis Investigative Site
Ghent, Belgium
Recruiting

Canada

Novartis Investigative Site
Hamilton, Ontario, Canada
Recruiting
Novartis Investigative Site
Toronto, Ontario, Canada
Recruiting
Novartis Investigative Site
Montreal, Quebec, Canada
Recruiting
Novartis Investigative Site
Montreal, Quebec, Canada
Recruiting

China

Novartis Investigative Site
Beijing, China
Recruiting

Denmark

Novartis Investigative Site
Copenhagen, Denmark
Recruiting

Finland

Novartis Investigative Site
Helsinki, Finland
Recruiting

France

Novartis Investigative Site
Nantes, France
Recruiting
Novartis Investigative Site
Paris, France
Recruiting
Novartis Investigative Site
Paris, France
Recruiting
Novartis Investigative Site
Pierre-Bénite, France
Recruiting
Novartis Investigative Site
Villejuif, France
Recruiting

Germany

Novartis Investigative Site
Munich, Bavaria, Germany
Recruiting
Novartis Investigative Site
Regensburg, Bavaria, Germany
Recruiting
Novartis Investigative Site
Würzburg, Bavaria, Germany
Recruiting
Novartis Investigative Site
Frankfurt am Main, Hesse, Germany
Recruiting
Novartis Investigative Site
Cologne, North Rhine-Westphalia, Germany
Recruiting
Novartis Investigative Site
Leipzig, Saxony, Germany
Recruiting
Novartis Investigative Site
Berlin, Germany
Recruiting
Novartis Investigative Site
Hamburg, Germany
Recruiting
Novartis Investigative Site
Ulm, Germany
Recruiting

Greece

Novartis Investigative Site
Chaïdári, Greece
Recruiting

Hong Kong

Novartis Investigative Site
Hong Kong, Hong Kong
Recruiting

Israel

Novartis Investigative Site
Ramat Gan, Israel
Recruiting
Novartis Investigative Site
Tel Aviv, Israel
Recruiting

Italy

Novartis Investigative Site
Bologna, BO, Italy
Recruiting
Novartis Investigative Site
Monza, MB, Italy
Recruiting
Novartis Investigative Site
Milan, MI, Italy
Recruiting
Novartis Investigative Site
Milan, MI, Italy
Recruiting

78 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Nov 2015
Primary completion: 22 Feb 2036
Completion: 22 Feb 2036
Last update posted: 28 Oct 2025
Registered enrollment: 1,400
Registry id: NCT02445222

Cross-registrations

EU-CTR / CTIS (EudraCT)2014-001673-14

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.